Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A Series of Double-Blind, Placebo-Controlled, Randomized, Multicenter, Phase 2 Studies to Evaluate the Efficacy, Safety, and Dose-Response Relationship of Orally Administered URC102, a Novel URAT1 Inhibitor, in Korean Patients with Gout
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 전재범 | - |
| dc.date.accessioned | 2021-08-02T23:26:36Z | - |
| dc.date.available | 2021-08-02T23:26:36Z | - |
| dc.date.issued | 2017-11-07 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/30370 | - |
| dc.title | A Series of Double-Blind, Placebo-Controlled, Randomized, Multicenter, Phase 2 Studies to Evaluate the Efficacy, Safety, and Dose-Response Relationship of Orally Administered URC102, a Novel URAT1 Inhibitor, in Korean Patients with Gout | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | American College of Rheumatology | - |
| dc.citation.conferencePlace | San Diego, USA | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Jun, Jae Bum
- 서울 의과대학 (DEPARTMENT OF INTERNAL MEDICINE)